Model systems for rapid and slow induction of apoptosis obtained by inducible expression of pro-apoptotic proteins

Christian Maueröder1, Ricardo A Chaurio, Stephanie Platzer

  • 1Lehrstuhl für Mikrobiologie, Department Biologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.

Autoimmunity
|November 24, 2012
PubMed

Insights

Inducing apoptosis for cancer therapy can cause immune tolerance. This study uses a doxycycline-inducible system to trigger cell death via caspase-3 or Bid, creating effective cancer models.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Cancer therapy aims to kill tumor cells, often via apoptosis, but this can paradoxically promote tumor growth and immune evasion.
  • The optimal cell death strategy for cancer treatment remains debated.
  • Regulated gene expression systems offer a controlled method to study cell death induction.

Purpose of the Study:

  • To investigate the efficacy of pro-apoptotic proteins in inducing cancer cell death using a conditional suicide switch.
  • To compare the cell death kinetics induced by activated caspase-3 and Bid.
  • To establish cancer models for preclinical studies.

Main Methods:

  • Developed a doxycycline-inducible transgene expression system in Jurkat T-cells.
  • Tested pro-apoptotic proteins, including activated caspase-3 (revCasp-3) and truncated Bid (tBid).
  • Integrated suicide switches into human leukemia and murine melanoma cell lines for stable expression.

Main Results:

  • Both revCasp-3 and tBid effectively induced >95% cell death in cancer cell lines.
  • tBid induced rapid cell death (85% in 4-6 hours), while revCasp-3 showed slower kinetics (85% in 18-24 hours).
  • Established human and murine cell lines suitable for xenograft, syngeneic, and allogeneic cancer models.

Conclusions:

  • Conditional expression of revCasp-3 and tBid represents a potent strategy for inducing cancer cell death.
  • The distinct kinetics of tBid and revCasp-3 offer flexibility in therapeutic strategies.
  • These engineered cell lines provide valuable preclinical models for evaluating cancer therapies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...